White Paper

Revolutionizing Patient-Centric Supply Chains To Improve Vaccine Access

Source: Marken, a UPS company

By Dan Bell, Senior VP Innovation & Strategic Operations, and Vesna Stamenkovic, Director, Global Vaccine Lead at Marken

GettyImages-1284041821 asian vaccine

Global disruptions over the past several years have had an undeniable impact on the vaccine landscape, including research trends, risk assessment strategies, and supply chain obstacles. Although vaccines are one of the fastest growing markets in the pharmaceutical industry, they have always come with manufacturing and distribution challenges, and stakeholders must now adapt to accommodate a rapidly growing market with an increasingly patient-centric focus.

Transparent collaboration and innovation are essential to establishing an infrastructure that supports more agile business models and empowers widespread vaccine access, including for low- or middle-income countries (LMICs).

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online